1University of New South Wales, Sydney, NSW, Australia [email protected]
2Harvard Medical School, Boston, MA
Dr. Valenzuela reports being cofounder and chief executive officer of Skin2Neuron, which is developing a cell therapy for Alzheimer's disease. Dr. Pascual-Leone reports being cofounder and chief medical officer of Linus Health, which is developing digital technologies for diagnostic evaluation of brain health; being cofounder of TI Solutions, which is developing a device for noninvasive brain stimulation; and serving on the scientific advisory board for Neuroelectrics, Magstim, TetraNeuron, Skin2Neuron, MedRhythms, and Hearts Radiant. No other potential conflict of interest relevant to this letter was reported.
